Abiopharma

🔍 CASH JOHN (Executive)

Company: UR-ENERGY INC (URG)

Report Date: 2026-08-24

Detailed Transactions and Holdings:

• Acquired 77,751 shares of Common Shares at $1.0403 per share (Direct)
  Date: 2026-08-24 | Code: M | equity_swap_involved: false | shares_owned_after: 774,015.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 77,751 shares of Common Shares at $1.4103 per share (Direct)
  Date: 2026-08-24 | Code: S | equity_swap_involved: false | shares_owned_after: 696,264.00 | transaction_form_type: 4 | Footnotes: F2
• Sold 77,751 shares of Common share options (right to buy) at $1.0403 per share (Derivative)
  Date: 2026-08-24 | Code: M | Expires: 2026-08-27 | equity_swap_involved: false | shares_owned_after: 1,040,617.00 | transaction_form_type: 4 | Footnotes: F1, F3

Footnotes:

• F1: The options were exercised and the shares were acquired at $1.44 Canadian dollars, $1.0403 U.S. dollars is the equivalent price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7224).
• F2: The shares were sold at $1.9523 Canadian dollars, $1.4103 U.S. dollars is the equivalent of the sales price pursuant to the exchange rate realized as of the transaction date (Cdn$1.00 = US$0.7224).
• F3: The 77,751 options were granted on 8/27/2021 and vested and became exercisable as follows: 25,917 on 8/27/2022; 25,917 on 8/27/2023; and 25,917 on 8/27/2024.